🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Belgium / NCT05002335
Active, not recruiting Observational

Clinical and Radiological Outcomes of Medacta Shoulder System (BE)

NCT05002335 · tracked via the Priya Life Science Belgium tracker
Phase
Observational
Started
2020-10-06
Last updated
2025-09-29

Condition(s) studied

Primary OsteoarthritisSecondary OsteoarthritisRotator Cuff Tear ArthropathyRheumatoid Arthritis ShoulderAvascular NecrosisFractureRevision of Shoulder Arthroplasty

Investigational drug(s) / intervention(s)

Medacta Shoulder System

Medacta Shoulder System: Performance of Total Shoulder Arthroplasty (anatomic/reverse) with Medacta Shoulder System

Study summary

This is a post-market surveillance study on Medacta Shoulder System

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients older than 18 years * Patient with one of the following diagnosis: 1. Primary osteoarthritis 2. Secondary osteoarthritis 3. Cuff tear arthropathy; insufficient rotator cuff 4. Acute fracture (\<21d) 5. Rheumatoid or inflammatory arthritis 6. Avascular necrosis 7. Other posttraumatic condition 8. Revision of shoulder arthroplasty Exclusion Criteria: * Patients with malignant diseases (at the time of surgery) * Patients with proven or suspect infections (at the time of surgery) * Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery) * Patients with known incompatibility or allergy to products materials (at the time of surgery)

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
AZ Sint-Jan Bruges Belgium
AZ Sint-Lucas Bruges Belgium
Clinique St-Luc Bouge Namur Belgium

More Medacta International SA trials in Belgium

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05002335 on ClinicalTrials.gov ↗ ← All trials in Belgium